🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mankind Pharma Limited (BOM:543904)
India flag India · Delayed Price · Currency is INR
2,660.00
+30.00 (1.14%)
At close: Nov 20, 2026

Mankind Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,100,765828,0511,000,400921,654--
Market Cap Growth
19.96%-17.23%8.54%---
Enterprise Value
1,131,110879,179960,198902,241--
Last Close Price
2660.002005.852422.202296.45--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
49.0443.2950.2548.18--
PS Ratio
7.165.808.208.98--
PB Ratio
6.265.006.879.63--
P/TBV Ratio
62.35497.03-12.00--
P/FCF Ratio
43.3633.1851.2450.17--
P/OCF Ratio
33.3326.5341.4542.82--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
7.366.167.878.79--
EV/EBITDA Ratio
27.3824.2231.0735.87--
EV/EBIT Ratio
34.5831.1938.2841.96--
EV/FCF Ratio
44.5535.2349.1849.11--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.300.380.580.020.020.14
Debt / EBITDA Ratio
1.321.732.740.080.090.44
Debt / FCF Ratio
2.132.534.360.110.171.94
Net Debt / Equity Ratio
0.160.250.41-0.33-0.18-0.06
Net Debt / EBITDA Ratio
0.681.131.95-1.26-0.71-0.20
Net Debt / FCF Ratio
1.091.653.08-1.73-1.32-0.87
Asset Turnover
0.530.510.620.950.931.00
Inventory Turnover
2.062.012.012.171.841.69
Quick Ratio
0.820.610.722.021.140.65
Current Ratio
1.351.071.233.102.321.68
Return on Equity (ROE)
13.56%12.45%16.62%22.57%18.79%25.99%
Return on Assets (ROA)
7.76%6.85%10.02%17.65%13.59%18.47%
Return on Invested Capital (ROIC)
12.54%11.36%14.83%27.47%20.42%29.77%
Return on Capital Employed (ROCE)
14.10%13.10%11.40%21.80%20.20%28.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
2.04%2.31%1.99%2.08%--
FCF Yield
2.31%3.01%1.95%1.99%--
Payout Ratio
-2.16%----
Buyback Yield / Dilution
-0.67%-2.13%-0.88%-0.14%-0.00%-
Total Shareholder Return
-0.67%-2.13%-0.88%-0.14%-0.00%-